WebApr 15, 2024 · Innate Pharma (OTCMKTS:IPHYF – Get Rating) and Sangamo Therapeutics (NASDAQ:SGMO – Get Rating) are both small-cap medical companies, but which is the superior business? ... Sangamo Therapeutics has a beta of 1.08, suggesting that its stock price is 8% more volatile than the S&P 500. Profitability. This table compares Innate … WebView live Innate Pharma chart to track its stock's price action. Find market predictions, IPHYF financials and market news.
Innate Pharma - IPHYF Short Interest Ratio & Short Volume
WebIPHYF -1.58% DJIA -1.19% Russell 2K -2.56% Health Care/Life Sciences -0.93% Overview Data not available. Overview Research & Ratings Options Stocks: Real-time U.S. stock … WebInnate Pharma - Class A (IPHYF) Stock Price, Quote, News & History Nasdaq Innate Pharma - Class A (IPHYF) Add to Watchlist Add to Portfolio Quotes Summary Real-Time … incorrect syntax near catalog_collation
Innate Pharma - Class A (IPHYF) Pre-Market Quotes Nasdaq
WebJan 27, 2024 · Company Profile IPHYF Business Description Innate Pharma SA is a clinical-stage biotechnology company. The company is engaged in discovering and developing … WebFind real-time IPHYF - Innate Pharma SA stock quotes, company profile, news and forecasts from CNN Business. WebFeb 20, 2024 · Innate Pharma SA (IPHYF) Technical Analysis 27 Followers Portfolio Summary of all the Indicators 1 Day 3 Days 1 Week 2 Weeks 1 Month Advanced Chart > Innate Pharma SA (IPHYF) Pivot Points Feb 20, 2024, 02:06 AM Innate Pharma SA (IPHYF) Moving Averages Feb 20, 2024, 02:06 AM Innate Pharma SA (IPHYF) Technical Indicators … incorrect syntax near blob_storage